Amit Kumar, Chief Executive Officer at Anixa Biosciences Inc (ANIX), bought 5,000 shares at $3.47 ($17K) on 2026-07-31, disclosed to the SEC on 2026-08-03.
CEO Amit Kumar purchased 5,000 shares for $17,350, marking the largest insider purchase in the company's history, signaling confidence in the stock's potential. This move comes shortly after the company was upgraded to a Zacks Rank #1 (Strong Buy) on July 22, 2026.
The stock is up 14.67% over the last 90 days and currently trades at $3.44, sitting 45.15% above its 52-week low of $2.37 but still down 36.96% from its high of $5.46.
1) Zacks Rank upgrade to Strong Buy on July 22, 2026; 2) Advancement of the breast cancer vaccine and CAR-T therapies, highlighted as a 'pivotal year' by CEO Amit Kumar in February 2026; 3) The largest insider purchase in company history, occurring on July 31, 2026.
The stock is currently trading at a forward P/E of -10.26, indicating the company is not yet profitable, and short interest remains low at 3.39% of the float.
Nothing distinguishes this filing.
| Filing → |
| ANIX | BUY | 2026-09-11 | $14K | — | Filing → |
| ANIX | BUY | 2026-07-28 | $17K | — | Filing → |
| ANIX | BUY | 2026-07-27 | $11K | — | Filing → |